Inhibitors of Phospholipases A2 and Their Use for the Treatment of Neurological Disorders
Publisher
Springer New York
Reference248 articles.
1. Abraham I. M., Harkany T., Horvath K. M., and Luiten P. G. (2001). Action of glucocorticoids on survival of nerve cells: promoting neurodegeneration or neuroprotection? J.-Neuroendocrinol. 13:749–760.
2. Adibhatla R. M. and Hatcher J.-F. (2003). Citicoline decreases phospholipase A2 stimulation and hydroxyl radical generation in transient cerebral ischemia. J.-Neurosci. Res. 73:308–315.
3. Adibhatla R. M. and Hatcher J.-F. (2006). Phospholipase A2, reactive oxygen species, and lipid peroxidation in cerebral ischemia. Free Radic. Biol. Med. 40:376–387.
4. Adibhatla R. M., Hatcher J.-F., and Dempsey R. J.-(2002). Citicoline: neuroprotective mechanisms in cerebral ischemia. J.-Neurochem. 80:12–23.
5. Adibhatla R. M., Hatcher J.-F., and Dempsey R. J.-(2003). Phospholipase A2, hydroxyl radicals, and lipid peroxidation in transient cerebral ischemia. Antioxid. Redox Signal. 5:647–654.